Leaps by Bayer
Germanyleaps.bayer.com
Overview
Leaps by Bayer is the strategic impact investment unit of Bayer. By accelerating transformative biotechnologies, they aim to shift key paradigms in life science, changing the world for better . In health, they pursue breakthroughs that could set new standards in medical care, moving from treating symptoms to curing or preventing diseases. In agriculture, they drive innovations that could nourish a growing population while restoring the planet .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| WellTheory | Oct 2025 | Series A | Co-investor |
| NuCicer | Jul 2025 | Series A | Co-investor |
| Indapta | Dec 2024 | Early Funding | Co-investor |
| Sound | Dec 2024 | Series D Extension | Co-investor |
| Senti Biosciences | Dec 2024 | PIPE | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.